Table 3.
Recurrent identical amplicons observed in at least two tumors
| Chromosome | Start positiona | End positiona | Candidate genes | Maximum ratio | Number of cases | |
| MBC | BLC | |||||
| 1q21.2–21.3 | 148.109 | 150.70 | SNX27, FLG, S100, LRN | 2.2 | 3 | 0 |
| 8p11.21 | 40.01 | 42.35 | MYST3, ANK1 | 2.9 | 3 | 0 |
| 8q24 | 122.64 | 128.80 | MYC, KIAA0196 | 2.3 | 2 | 2 |
| 10p15.3 | 0.25 | 1.00 | ZMYND11 | 2.3 | 3 | 0 |
| 12p13.32–13.33 | 2.46 | 4.31 | CCND2 | 2.8 | 2 | 0 |
| 12p13.2-13.31 | 5.16 | 6.37 | TNFRSF1A, NTF3, LTBR, CD9 | 2.7 | 3 | 0 |
| 12p13.2 | 7.80 | 11.7 | PRR4, Nanog, CD69, STELLA/DPPA3, PHC1 | 3.8 | 3 | 0 |
| 12p13.2 | 11.95 | 12.11 | ETV6, BCL2L14 | 9.1 | 3 | 0 |
| Xp11.22 | 51.21 | 53.95 | SSX1, SSX2 | 2.8 | 0 | 2 |
| Xq28 | 152.66 | 153.69 | MTCP1, TZ, TKTL1, FLNA | 2.8 | 3 | 1 |
MBC, medullary breast carcinoma; BLC, basal-like carcinoma. aUCSC Genome Browser on Human May 2004 Assembly; positions are given in megabases.